Development Level

Tclin 3 | 602

Disease

Autistic Disorder 3 | 320
Carcinoma 3 | 2,147
atypical teratoid / rhabdoid tumor 3 | 4,369
medulloblastoma, large-cell 3 | 6,234
primitive neuroectodermal tumor 3 | 3,031
Anxiety 2 | 24
Ataxia 2 | 15
Benzodiazepine Induced Sedation 2 | 8
Benzodiazepine Maintained Anesthesia 2 | 8
Benzodiazepine Toxicity 2 | 8
Epilepsy 2 | 346
General anesthesia 2 | 53
Insomnia 2 | 20
Sedation as Adjunct to Anesthesia 2 | 15
Tonic-clonic epilepsy 2 | 47
astrocytic glioma 2 | 2,241
astrocytoma 2 | 1,493
glioblastoma 2 | 5,572
medulloblastoma 2 | 1,524
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
posterior fossa group A ependymoma 2 | 1,511
psoriasis 2 | 6,685
Absence seizure 1 | 12
Alcohol withdrawal delirium 1 | 9
Alcohol withdrawal syndrome 1 | 9
Alcoholism 1 | 14
Allergic conjunctivitis 1 | 25
Androgen insensitivity syndrome 1 | 11
Anemia of chronic renal failure 1 | 4
Anxiety associated with Menopause 1 | 7
Aplastic anemia 1 | 18
Atonic seizure 1 | 4
Benign intracranial hypertension 1 | 3
Bilateral Anorchia 1 | 3
Bilateral orchidectomy 1 | 3
Breast Neoplasms, Male 1 | 4
Cerebral ischemia 1 | 12
Chemotherapy-Induced Hypogonadism 1 | 3
Congenital hypoplastic anemia 1 | 8
Conscious sedation 1 | 10
Corneal abrasion 1 | 6
Corneal ulcer 1 | 9
Cyclitis 1 | 6
Deficiency of testosterone biosynthesis 1 | 3
Delayed Puberty 1 | 10
Disorders of initiating and maintaining sleep 1 | 8
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13 1 | 1
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 5 (disorder) 1 | 1
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19 1 | 1
Epilepsy, Childhood Absence, Susceptibility To, 4 1 | 1
Feeling agitated 1 | 7
Gestational Diabetes 1 | 17
Gynecomastia 1 | 13
Hereditary angioneurotic edema 1 | 3
Herpes zoster keratitis 1 | 6
Hormone receptor positive malignant neoplasm of breast 1 | 10
Hypogonadotropic hypogonadism 1 | 4
Hypopituitarism 1 | 36
Hypospadias 1, X-Linked 1 | 2
Induce Anterograde Amnesia 1 | 9
Initial insomnia 1 | 8
Insulin Resistance 1 | 48
Iridocyclitis 1 | 12
Iritis 1 | 9
Klinefelter's syndrome 1 | 59
LHRH Deficiency 1 | 3
Male hypogonadism 1 | 3
Malignant tumor of prostate 1 | 11
Metastatic Prostate Carcinoma 1 | 18
Migraine Prevention 1 | 22
Mixed anxiety and depressive disorder 1 | 10
Myoclonic Epilepsy, Juvenile 1 | 7
Myoclonic seizure 1 | 4
Narcoanalysis 1 | 3
Ovarian Cysts 1 | 34
Pain with Tension and Anxiety 1 | 6
Peptic ulcer 1 | 22
Post-Op Ocular Inflammation 1 | 10
Pre-Op Apprehension 1 | 10
Preoperative Anxiety 1 | 9
Primary Hypogonadism due to Bilateral Torsion 1 | 3
Prostatic Intraepithelial Neoplasias 1 | 11
Prostatic hypertrophy 1 | 9
Pseudohermaphroditism 1 | 16
Punctate Epithelial Keratopathy 1 | 6
Rosacea 1 | 18
Sedation 1 | 11
Sedation in Intubated Patients 1 | 8
Seizure disorder 1 | 4
Severe Insomnia 1 | 7
Severe anxiety (panic) 1 | 7
Tension-type headache 1 | 10
Tetanus 1 | 66
Tetanus Adjunct Treatment 1 | 8
Undescended testicle 1 | 3
Uveitis 1 | 103
Withdrawal disorder 1 | 19

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Ion Channel 2 | 341
Nuclear Receptor 1 | 48

Grant Application

1R21NS042363-01 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Gamma-aminobutyric acid receptor subunit alpha-4 GABRA4 Tclin Ion Channel -1.23686 16.0 235
Gamma-aminobutyric acid receptor subunit alpha-1 GABRA1 Tclin Ion Channel -1.76425 55.7 254
Androgen receptor AR Tclin Nuclear Receptor -3.78107 6683.7 1366